Efficacy and toxicity of the FLAG/Daunoxome® association in children with relapsed or resistant acute myeloid leukemia (AML).

被引：0
|
作者：
Rizzari, C
Micalizzi, C
Locatelli, F
Maffeis, B
Daldossi, S
Ladogana, S
Casale, F
Fagioli, F
Lippi, A
Colombini, A
Pession, A
机构：
[1] Univ Milano Bicocca, Osped S Gerardo, Monza, Italy
[2] IRCCS G Gaslini, Genoa, Italy
[3] IRCCS Policlin S Matteo, Pavia, Italy
[4] Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy
[5] Univ Naples Federico II, Naples, Italy
[6] Osped Infantile Regina Margherita, Turin, Italy
[7] Azienda Osped Meyer, Florence, Italy
[8] Univ Bologna, I-40126 Bologna, Italy
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1334
引用
收藏
页码：344A / 344A
页数：1
相关论文
共 50 条
  • [1] Liposomal daunorubicin (DaunoXome) for treatment of relapsed meningeal acute myeloid leukemia
    PP Piccaluga
    G Visani
    G Martinelli
    A Isidori
    M Malagola
    M Rondoni
    M Baccarani
    S Tura
    [J]. Leukemia, 2002, 16 : 1880 - 1881
  • [2] Liposomal daunorubicin (DaunoXome) for treatment of relapsed meningeal acute myeloid leukemia
    Piccaluga, PP
    Visani, G
    Martinelli, G
    Isidori, A
    Malagola, M
    Rondoni, M
    Baccarani, M
    Tura, S
    [J]. LEUKEMIA, 2002, 16 (09) : 1880 - 1881
  • [3] Gemtuzumab Ozogamicin Containing Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia (AML) in Children
    Liu, Anthony Pak-Yin
    Leung, Alex Wing-Kwan
    Cheuk, Daniel Ka-Leung
    Lee, Vincent
    Ha, Shau-Yin
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2018, 40 (02) : 163 - 168
  • [4] COSTS OF RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML) IN COLOMBIA
    Lasalvia, P.
    Gil, Rojas Y.
    Arciniegas Moreno, K.
    Saturnino, Ltm
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S59 - S59
  • [5] Impact of pharmacokinetics on the toxicity and efficacy of clofarabine in patients with relapsed or refractory acute myeloid leukemia
    Buettner, Bozena
    Knoth, Holger
    Kramer, Michael
    Oertel, Reinhard
    Seeling, Andreas
    Sockel, Katja
    von Bonin, Malte
    Stoelzel, Friedrich
    Alakel, Nael
    Platzbecker, Uwe
    Roellig, Christoph
    Ehninger, Gerhard
    Bornhaeuser, Martin
    Schetelig, Johannes
    Middeke, Jan Moritz
    [J]. LEUKEMIA & LYMPHOMA, 2017, 58 (12) : 2865 - 2874
  • [6] Phase I study of liposomal daunorubicin (daunoxome) in relapsed and refractory acute myeloid leukemia.
    Lerchenmüller, C
    Büchner, T
    Berdel, WE
    [J]. BLOOD, 1999, 94 (10) : 233B - 233B
  • [7] OUTCOMES OF SALVAGE CHEMOTHERAPY REGIMENS IN CHILDREN AND ADOLESCENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML)
    Tak, Himangi
    Trivedi, Maharshi
    Joshi, Nitin
    Panchal, Harsha
    [J]. PEDIATRIC BLOOD & CANCER, 2023, 70 : S553 - S553
  • [8] Gemtuzumab ozogamicin with FLAG-IDA is effective for children in relapsed/refractory acute myeloid leukemia.
    Cho, Bin
    Kim, Sun Young
    Lee, Dae Hyoung
    Kwon, Young Joo
    Park, Young Shil
    Hwang, Hui Sung
    Park, Ji Kyoung
    Jang, Pil Sang
    Chung, Nak Gyun
    Jeong, Dae-Chul
    Kim, Hack Ki
    [J]. BLOOD, 2006, 108 (11) : 218B - 218B
  • [9] The use of liposomal daunorubicin (DaunoXome) in acute myeloid leukemia
    Fassas, A
    Anagnostopoulos, A
    [J]. LEUKEMIA & LYMPHOMA, 2005, 46 (06) : 795 - 802
  • [10] FLAG salvage therapy combined with idarubicin in relapsed/refractory acute myeloid leukemia
    Westhus, Jonas
    Noppeney, Richard
    Duehrsen, Ulrich
    Hanoun, Maher
    [J]. LEUKEMIA & LYMPHOMA, 2019, 60 (04) : 1014 - 1022
12345